London
· Delayed Price · Currency is GBP · Price in GBXMYCELX Technologies Statistics
Total Valuation
MYCELX Technologies has a market cap or net worth of GBP 9.15 million. The enterprise value is 8.58 million.
| Market Cap | 9.15M |
| Enterprise Value | 8.58M |
Important Dates
The next estimated earnings date is Tuesday, December 24, 2024.
| Earnings Date | Dec 24, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MYCELX Technologies has 24.41 million shares outstanding. The number of shares has decreased by -0.04% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 24.41M |
| Shares Change (YoY) | -0.04% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 19.22% |
| Owned by Institutions (%) | 14.49% |
| Float | 13.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.23 |
| PB Ratio | 1.87 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.04 |
| EV / Sales | 1.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.84 |
Financial Position
The company has a current ratio of 2.93, with a Debt / Equity ratio of 0.23.
| Current Ratio | 2.93 |
| Quick Ratio | 1.37 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.85 |
| Interest Coverage | -345.34 |
Financial Efficiency
Return on equity (ROE) is -46.97% and return on invested capital (ROIC) is -29.49%.
| Return on Equity (ROE) | -46.97% |
| Return on Assets (ROA) | -24.82% |
| Return on Capital (ROIC) | -29.49% |
| Revenue Per Employee | 1.17M |
| Profits Per Employee | -469,751 |
| Employee Count | 6 |
| Asset Turnover | 0.85 |
| Inventory Turnover | 1.99 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.02% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -38.02% |
| 50-Day Moving Average | 40.62 |
| 200-Day Moving Average | 51.30 |
| Relative Strength Index (RSI) | 35.97 |
| Average Volume (20 Days) | 106,036 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MYCELX Technologies had revenue of GBP 6.99 million and -2.82 million in losses. Loss per share was -0.12.
| Revenue | 6.99M |
| Gross Profit | 1.87M |
| Operating Income | -3.28M |
| Pretax Income | -2.63M |
| Net Income | -2.82M |
| EBITDA | -2.76M |
| EBIT | -3.28M |
| Loss Per Share | -0.12 |
Balance Sheet
The company has 1.64 million in cash and 1.06 million in debt, giving a net cash position of 576,045 or 0.02 per share.
| Cash & Cash Equivalents | 1.64M |
| Total Debt | 1.06M |
| Net Cash | 576,045 |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 4.60M |
| Book Value Per Share | 0.20 |
| Working Capital | 2.92M |
Cash Flow
In the last 12 months, operating cash flow was -1.23 million and capital expenditures -26,112, giving a free cash flow of -1.25 million.
| Operating Cash Flow | -1.23M |
| Capital Expenditures | -26,112 |
| Free Cash Flow | -1.25M |
| FCF Per Share | -0.05 |
Margins
Gross margin is 26.69%, with operating and profit margins of -46.88% and -40.30%.
| Gross Margin | 26.69% |
| Operating Margin | -46.88% |
| Pretax Margin | -37.54% |
| Profit Margin | -40.30% |
| EBITDA Margin | -39.39% |
| EBIT Margin | -46.88% |
| FCF Margin | -17.93% |
Dividends & Yields
MYCELX Technologies does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.04% |
| Shareholder Yield | 0.04% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MYCELX Technologies has an Altman Z-Score of -3.17. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.17 |
| Piotroski F-Score | n/a |